Taiho Ventures, LLC
Corporate VCMenlo Park · Seed–Series B · 7 people tracked
Investment thesis
Taiho Ventures aims to generate significant value by investing in the global biotech venture ecosystem while sourcing innovative science to benefit its parent company, Taiho Pharmaceutical Co., Ltd. As a corporate venture arm, it focuses on biotechnology and life-science innovation with a global mandate, connecting cutting-edge research and emerging companies to the strategic interests of the pharmaceutical parent.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 21 of 24 portfolio companiesBiotech ×21Medical Devices ×10Healthtech ×6AI & Machine Learning ×3Deep Tech ×2Digital Health ×1Longevity ×1
HQs:United States×9Japan×1Netherlands×1
Investments · 24 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 23 dated
ORIC Pharmaceuticals is a clinical-stage oncology company founded in 2014 to develop cancer therapies that address treatment resistance, with the aim of extending the effectiveness of existing therapies.
BiotechHealthtechSouth San Francisco, US
Richard Heyman(Chairman, Founder, Scientific Advisory Board)Jacob M. Chacko(Executive Officer, Director)Dominic Piscitelli(Chief Financial Officer)Pratik Multani(Chief Medical Officer)Mardi Dier(Director)Charles Sawyers(Founder, Scientific Advisory Board)
Nextcure is a clinical-stage biopharmaceutical company developing immunotherapies targeting IO pathways, with a focus on oncology applications.
BiotechBeltsville, US
Timothy Mayer(Executive Officer)Michael Richman(Executive Officer, Director)Elaine V. Jones(Director)Udayan Guha(Executive Officer)Anne Borgman(Director)Steven P. Cobourn(Executive Officer)
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
BiotechHealthtechMedical DevicesFoster City, US
Nenad Tomasevic(Executive Officer, Director)Ivan Trifunovich(Director)John Wesley(Director)
Board seatSakae Asanuma· per SEC Form D
BiotechBoston, US
Darlene Deptula-Hicks(Executive Officer)Rachel Humphrey(Officer and a Manager)Yunxia Yang(Manager)James Trenkle(Manager)Scott Phillips(Executive Officer)
BoardDavid Parry(Manager)
Board seatSakae Asanuma· per SEC Form D · $75M raise · filed Jan 2025
Breakpoint Therapeutics develops cancer treatments based on modulating DNA damage response pathways.
BiotechMedical Devices
cellvie develops Therapeutic Mitochondria Transplantation, a technique that augments or replaces failing mitochondria to restore cellular energy metabolism, with initial applications in ischemia-reperfusion injury (starting with kidney transplantation) and in mitochondria-enabled gene therapy for the genetic skin disease Epidermolysis Bullosa.
BiotechLongevityMedical Devices
Cullinan Therapeutics develops clinical-stage T cell engager therapies targeting autoimmune diseases and cancer, leveraging immune modulation expertise to advance high-impact therapeutic candidates.
BiotechDigital Health
Epibiologics develops protein degradation medicines using protein sciences and antibody engineering capabilities.
BiotechMedical DevicesSan Mateo, US
Jason Coloma(Director)Ann Lee-Karlon(Executive Officer, Director)Samuel Bjork(Director)Alexandra Cantley(Director)Mitchell Mutz(Executive Officer, Director)Seiji Miyahara(Director)
BiotechMedical DevicesNew Haven, US
Scott Phillips(Executive Officer)Leyi Wang(Manager)Rebecca Frey(Manager)
BoardTim Shannon(Manager)Liam Ratcliffe(Manager)
BiotechSouth San Francisco, US
Jonathan Drachman(Director)Joanne Viney(Director)Joseph Bailes(Director)Ronald Hunt(Director)Andrew Robbins(Director)Mark Chin(Director)
Light Horse Therapeutics is a small molecule drug discovery company that uses proprietary precision gene editing and target-agnostic functional screens to identify functionally critical drug targets and develop small molecule drugs against them.
AI & Machine LearningBiotech
Magnet Biomedicine develops TrueGlue™, a molecular glue discovery platform for designing small molecule therapeutics that induce novel protein-protein interactions to treat cancer and immune disorders.
AI & Machine LearningBiotechMedical Devices
Benjamin F. Cravatt, PhD(Founder & Advisor)David A. Spiegel, MD, PhD(Founder & Advisor)Michael Rosbash, PhD(Founder & Advisor)Richa Saxena, PhD(Founder & Advisor)Stuart Schreiber, PhD(Founder & Advisor)
Orna Therapeutics develops RNA and lipid nanoparticle (LNP) based therapies for treating diseases including oncology and cell therapy applications.
AI & Machine LearningBiotechMedical Devices
Joe Bolen(Chief Executive Officer)Joe Bolen, Ph.D.(Chief Executive Officer)Hope D'Oyley-Gay, JD(Chief Legal Officer)Ciaran Lawlor, Ph.D.(Chief Operating Officer)Frank Neumann, M.D., Ph.D.(Chief Medical Officer)Siva Sakhamuri(Chief Technology Officer)
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology.
BiotechHealthtechMedical Devices
Theolytics develops oncolytic adenovirus-based immunotherapies to overcome the tumor microenvironment barriers in solid cancers.
BiotechDeep TechMedical Devices
Microfluidics and machine learning platform for discovering modulators of biomolecular condensates.
BiotechCambridge, US
Tuomas Knowles(Director)Samuel Cohen(Director)George Martin(Executive Officer, Director)Stephanie Torruella(Executive Officer)Preet Makkar(Executive Officer)Martin Kulander(Executive Officer)
Vertero is a biotech company developing oral therapeutics that target peripheral drivers of neurodegenerative diseases such as Parkinson's.
BiotechHealthtech
Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer.
BiotechHealthtechMedical DevicesWatertown, US
Daniel J. Hicklin(Founder, President, Chief Executive Officer, and Board member)Luke Evnin(Co-founder, Board member (Chairman))Daniel Hicklin(Executive Officer, Director)Alon Lazarus(Director)David Cordo(Executive Officer)
BoardChristoph Westphal(Director)
LiberoThera is a drug discovery company using cell-free membrane protein preparation technology and non-natural amino acid incorporation technology to develop antibody-based therapeutics, including antibodies targeting GPCRs such as anti-CCR8.
BiotechDeep Tech
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
IPOs and acquisitions across the tracked portfolioORIC PharmaceuticalsNASDAQ: ORICvisit ww.nextcure.comNASDAQ: NXTC
Portfolio news
latest coverage across their companiesvisit ww.nextcure.com · investing.com · Jul 15, 2026
Cullinan Oncology · investing.com · Jun 23, 2026
Orna · news.crunchbase.com · Feb 18, 2026
Frequently asked questions
- What stage does Taiho Ventures, LLC invest at?
- Taiho Ventures, LLC invests at the Seed, Series A, Series B stages.
- What sectors does Taiho Ventures, LLC focus on?
- Taiho Ventures, LLC focuses on Biotech, Medical Devices.
- Where is Taiho Ventures, LLC located?
- Taiho Ventures, LLC is headquartered in Menlo Park, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Fluke Venture Partners is a Pacific Northwest venture firm that has funded technology, healthcare, and consumer companies for over three decades, working with management teams as long-term partners from early stages onward.
Roadmap Capital Inc. is an investment platform providing co-investment access to private companies in technology and healthcare/medtech sectors.